JP2004505932A5 - - Google Patents

Download PDF

Info

Publication number
JP2004505932A5
JP2004505932A5 JP2002517105A JP2002517105A JP2004505932A5 JP 2004505932 A5 JP2004505932 A5 JP 2004505932A5 JP 2002517105 A JP2002517105 A JP 2002517105A JP 2002517105 A JP2002517105 A JP 2002517105A JP 2004505932 A5 JP2004505932 A5 JP 2004505932A5
Authority
JP
Japan
Prior art keywords
product
lactoferrin
labeled
tumor
product according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002517105A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505932A (ja
Filing date
Publication date
Priority claimed from GBGB0019412.6A external-priority patent/GB0019412D0/en
Application filed filed Critical
Publication of JP2004505932A publication Critical patent/JP2004505932A/ja
Publication of JP2004505932A5 publication Critical patent/JP2004505932A5/ja
Pending legal-status Critical Current

Links

JP2002517105A 2000-08-08 2001-08-07 造影剤としての放射性標識金属輸送タンパク質 Pending JP2004505932A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019412.6A GB0019412D0 (en) 2000-08-08 2000-08-08 New imaging agent
PCT/GB2001/003531 WO2002011772A2 (en) 2000-08-08 2001-08-07 Radiolabelled metal transport proteins as imaging agents

Publications (2)

Publication Number Publication Date
JP2004505932A JP2004505932A (ja) 2004-02-26
JP2004505932A5 true JP2004505932A5 (enExample) 2005-03-03

Family

ID=9897174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002517105A Pending JP2004505932A (ja) 2000-08-08 2001-08-07 造影剤としての放射性標識金属輸送タンパク質

Country Status (7)

Country Link
US (2) US7160536B2 (enExample)
EP (1) EP1307240A2 (enExample)
JP (1) JP2004505932A (enExample)
AU (1) AU2001278585A1 (enExample)
CA (1) CA2418383A1 (enExample)
GB (1) GB0019412D0 (enExample)
WO (1) WO2002011772A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019412D0 (en) * 2000-08-08 2000-09-27 Univ York New imaging agent
US20060083684A1 (en) * 2002-02-12 2006-04-20 Walton Paul H Method of radio-labelling biomolecules
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
DE102005051366A1 (de) * 2005-10-25 2007-04-26 Degussa Gmbh Drug Delivery Systeme
CA2627459C (en) * 2005-10-25 2011-08-09 Evonik Degussa Gmbh Preparations containing hyperbranched polymers
EP1982698A1 (de) * 2007-04-18 2008-10-22 Evonik Degussa GmbH Präparate zur gesteuerten Freisetzung von bioaktiven Naturstoffen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057617A (en) * 1975-05-15 1977-11-08 Abramovici J Method of labeling proteins with technetium
JPH08505119A (ja) 1992-07-06 1996-06-04 バイオミラ、インコーポレーテッド 接合目的のためのタンパク質の光活性化
GB0019412D0 (en) * 2000-08-08 2000-09-27 Univ York New imaging agent

Similar Documents

Publication Publication Date Title
JP3853354B2 (ja) 放射性標識ペプチドおよびタンパク質の自己放射線分解を防止する安定剤
Gaynor et al. The prevalence of metal-based drugs as therapeutic or diagnostic agents: beyond platinum
JP7242538B2 (ja) 放射線治療及び画像診断のための製剤
CA1173828A (en) Diagnostic composition for radiologic imaging of neoplasms in the body and method of preparation
ES2736134T3 (es) Derivado peptídico de tiourea, compuesto marcado con radioisótopos que contiene el mismo y composición farmacéutica que contiene el mismo como ingrediente activo para tratar o diagnosticar el cáncer de próstata
RU2594167C2 (ru) Композиции пептидных радиоактивных индикаторов
ES2308778T3 (es) Composiciones de peptidos radiomarcados para dirigir a un sitio especifico.
KR20050119205A (ko) 갈륨-68을 얻는 방법, 갈륨-68의 용도 및 상기 방법의수행을 위한 장치
JPH10500411A (ja) ソマトスタチン結合性ペプチド−金属キレートコンジュゲート
EP2658581B1 (en) A conjugate of human albumin and 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid useful for the localization of radionuclides for diagnostic and therapeutic purposes
JP3558169B2 (ja) 新規化合物及びその製造方法並びに診断用薬剤
KR0175305B1 (ko) 방사능의약품 조성물의 제조방법
JP2000515847A (ja) ペプチド放射性医薬品用途
CN117159753A (zh) 放射性标记的伊文思蓝衍生物药物的制备方法及用途
CN1771058A (zh) 制备放射性标记的镓络合物的微波方法
JP2004505932A5 (enExample)
Mukiza et al. A review on technetium and rhenium based radiopharmaceuticals for diagnostic imaging and therapeutic nuclear medicine
Zhao et al. 68Ga-labeled dimeric and trimeric cyclic RGD peptides as potential PET radiotracers for imaging gliomas
CA1105815A (en) Red blood cell labelling kit
Ferro-Flores et al. Radiolabeled protein-inhibitor peptides with rapid clinical translation towards imaging and therapy
RU2568888C1 (ru) СПОСОБ И СОСТАВ ДЛЯ ПОЛУЧЕНИЯ РЕАГЕНТА ДЛЯ РАДИОНУКЛИДНОЙ ДИАГНОСТИКИ НА ОСНОВЕ МЕЧЕННОЙ ТЕХНЕЦИЕМ-99m 5-ТИО-D-ГЛЮКОЗЫ
CN109316609A (zh) 选择患者的方法
ES2223559T3 (es) Complejos de metales de transicion del grupo (vii) con ligandos aminopolicarboxilato multidentados y kit para producirlos.
KR20070106731A (ko) 방사성표지된 갈륨 복합체, 그의 합성방법 및 악성종양에서 egfr 발현의 pet 영상화를 위한 그의 용도
WO2023202730A2 (zh) 放射性伊文思蓝衍生物药物水溶液及其制备方法和用途